Duan, Jianchun

Assessment of blood tumor mutational burden as a potential biomarker for immunotherapy in patients with non-small cell lung cancer with use of a next-generation sequencing cancer gene panel

Wang, Z., Duan, J., Cai, S., Han, M., Dong, H., Zhao, J., Zhu, B., Wang, S., Zhuo, M., Sun, J., et al. (2019) · JAMA Oncology

Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics

Cited by 471

Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients

Ni, X., Zhuo, M., Su, Z., Duan, J., Gao, Y., Wang, Z., Zong, C., Bai, H., Chapman, A. R., Zhao, J., et al. (2013) · Proceedings of the National Academy of Sciences

Cancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalities

Cited by 454

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

Wang, Z., Zhao, J., Wang, G., Zhang, F., Zhang, Z., Zhang, F., Zhang, Y., Dong, H., Zhao, X., Duan, J., et al. (2018) · Cancer Research

Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics

Cited by 241

Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non–Small-Cell Lung Cancer

Bai, H., Wang, Z., Chen, K., Zhao, J., Lee, J. J., Wang, S., Zhou, Q., Zhuo, M., Mao, L., An, T., et al. (2012) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 199

Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial

Fan, Y., Zhao, J., Wang, Q., Huang, D., Li, X., Chen, J., Fang, Y., Duan, J., Zhou, C., Hu, Y., et al. (2021) · Journal of Thoracic Oncology

Lung Cancer Research StudiesLung Cancer Treatments and Mutations

Cited by 135

ARTEMIS-001: Phase 1 study of HS-20093, a B7-H3–targeting antibody-drug conjugate, in patients with advanced solid tumor.

Wang, J., Duan, J., Xing, L., Sun, Y., Guo, W., Wang, H., Chen, J., Han, L., Liu, B., Wang, Q., et al. (2023) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersMonoclonal and Polyclonal Antibodies Research

Cited by 28

Alterations in EGFR and related genes following neo-adjuvant chemotherapy in Chinese patients with non-small cell lung cancer

Wang, S., An, T., Duan, J., Zhang, L., Wu, M., Zhou, Q., Chen, J., Zhuo, M., Yang, L., Wang, Y., et al. (2013) · PLoS ONE

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 7